Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'The Market for RNA Interference Kits and Reagents' returned 9 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom RNA interference (RNAi) - Global Strategic Business Report   Global Industry Analysts, Inc., April 2011, Pages: 802 This report analyzes the worldwide markets for RNA interference (RNAi) in US$ Million by the following application areas: Drug Discovery and Target Validation, Reagents, and siRNA Synthesis RNAi - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 485 RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide RNAs termed si Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics   Business Insights, June 2007, Pages: 244 issues and patents RNAi markets and trends Chapter 1 Introduction Summary Introduction DNA to RNA to protein – a primer Antisense technologies RNA interference Overview and significance RNAi The Exploding RNAi Market & Future Direction Translating the Genome into a Large Market by 2009   Fuji-Keizai USA, Inc., Feb 2006, Pages: 130 Since its discovery in 1998 by two scientists, the naturally occurring RNA interference effect has been hailed as the hottest technical breakthrough in biological research in the last decade. It may Cell-Based Assays for Drug Discovery   TriMark Publications, Jan 2011, Pages: 100 that are brought about by gene modification (such as with RNA interference (RNAi) approaches) and/or drug (or compound) treatment. The purpose of this examination is to describe the specific segments of the global Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015   Axis Research Mind, Nov 2011, Pages: 644 Reagent Kit For Snp Array 6.0 Customers Calipers And Historx Joint Venture For Tissue-Based Integrated Solutions For Protein Quantification Of Biomarkers Cytocell Develops New Fgfr1 Fish Probe Affymetrix Molecular Diagnostics Markets   TriMark Publications, July 2011, Pages: 335 Assays 5.3 Solution-Phase Multiplexing 5.4 RNA Interference (RNAi) 5.4.1 Role of RNAi in Drug Target Validation 5.4.2 Other Companies involved in the RNAi Market 5.5 DNA Tags 5.6 Follow-on Optical Molecular Diagnostics in Infectious Disease Testing   TriMark Publications, July 2011, Pages: 365 Market 3.3 Infectious Disease Molecular Diagnostic Testing Markets 3.3.1 HIV 3.3.1.1 Disease Background and Statistics 3.3.1.2 Measuring Viral Loads 3.3.1.3 Instruments and MD Reagents 3.3.1.4 Method nanoKAP 2010: 17th International Conference on Detection Technologies - Conference Proceedings   Knowledge Press, Nov 2010, Pages: 320 automated detection - Sampling / preparation / pre-concentration / analysis - PCR vs. non-PCR based detection techniques - Reagent and reagentless detection systems - Point-of-care pathogen detection Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network